InsideArbitrage Event Driven Monitor – February 7, 2023
Quick updates on the event driven strategies we follow on InsideArbitrage. Merger Arbitrage Opiant Pharmaceuticals (OPNT) announced the expiration of the waiting period under the HSR Act, with respect to the previously announced agreement for Opiant to be acquired by Indivior. According to a New York Times report, Microsoft’s (MSFT) legal team expects the UK’s Competition and Markets Authority will oppose its planned purchase of Activision (ATVI). Chiesi Farmaceutici filed with the Austria Federal Competition Authority for its proposed acquisition of Amryt Pharma (AMYT). The Chile FNE disclosed that it has commenced its formal review of Fairfax Financial Holdings Limited’s proposed acquisition of Atlas Corp. (ATCO). The ‘go-shop’ period for Duck Creek Technologies (DCT) expired. You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here. Deal In The Works CVS Health Corp (CVS) is close to an agreement to buy primary care center operator Oak Street Health Inc (OSH) for about $10.5 billion including debt, the Wall Street Journal reported. Republic First Bancorp (FRBK) reiterated that activist investor George E. Norcross III, Avery Conner Capital Trust, and its trustees refuse to sign a standard non-disclosure agreement to participate in its strategic review process. Insider...
Only plus or premium subscribers can access this post. Subscribe today.
